Targeting the NLRP3 inflammasome in cardiovascular diseases.
Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW, Abbate A.
Toldo S, et al. Among authors: van tassell bw.
Pharmacol Ther. 2022 Aug;236:108053. doi: 10.1016/j.pharmthera.2021.108053. Epub 2021 Dec 11.
Pharmacol Ther. 2022.
PMID: 34906598
Free PMC article.
Review.